# OncoBayes2
Bayesian logistic regression with optional EX/NEX modeling enables flexible borrowing from historical or concurrent data. The safety model supports dose-escalation in adaptive Phase I oncology trials with multiple drugs. See Neuenschwander et al. (2008, 2016) for methodology.
